GB201608591D0 - Compound - Google Patents

Compound

Info

Publication number
GB201608591D0
GB201608591D0 GBGB1608591.2A GB201608591A GB201608591D0 GB 201608591 D0 GB201608591 D0 GB 201608591D0 GB 201608591 A GB201608591 A GB 201608591A GB 201608591 D0 GB201608591 D0 GB 201608591D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1608591.2A
Other versions
GB2550363A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coegin Pharma AS
Original Assignee
Avexxin AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avexxin AS filed Critical Avexxin AS
Priority to GB1608591.2A priority Critical patent/GB2550363A/en
Publication of GB201608591D0 publication Critical patent/GB201608591D0/en
Publication of GB2550363A publication Critical patent/GB2550363A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1608591.2A 2016-05-16 2016-05-16 Compound Withdrawn GB2550363A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1608591.2A GB2550363A (en) 2016-05-16 2016-05-16 Compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1608591.2A GB2550363A (en) 2016-05-16 2016-05-16 Compound

Publications (2)

Publication Number Publication Date
GB201608591D0 true GB201608591D0 (en) 2016-06-29
GB2550363A GB2550363A (en) 2017-11-22

Family

ID=56320484

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1608591.2A Withdrawn GB2550363A (en) 2016-05-16 2016-05-16 Compound

Country Status (1)

Country Link
GB (1) GB2550363A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007019251A2 (en) * 2005-08-04 2007-02-15 Apogee Biotechnology Corporation Sphingosine kinase inhibitors and methods of their use
AU2010302584B2 (en) * 2009-10-02 2015-09-10 Avexxin As Anti inflammatory 2-oxothiazoles and 2 -oxooxazoles
US10301294B2 (en) * 2013-03-13 2019-05-28 The Broad Institute Inc. Compounds for the treatment of tuberculosis

Also Published As

Publication number Publication date
GB2550363A (en) 2017-11-22

Similar Documents

Publication Publication Date Title
GB201602934D0 (en) Compounds
GB201604020D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201610854D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201620119D0 (en) Compounds
GB201608777D0 (en) Compounds
HK1255832A1 (en) Pyranodipyridine compound
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
GB201521524D0 (en) Compound
GB201613946D0 (en) Compounds
GB201617103D0 (en) Compound
GB201621520D0 (en) Compounds
GB201612652D0 (en) Novel compound
GB201604029D0 (en) Compounds
GB201622362D0 (en) Compounds
GB201610497D0 (en) Compound
GB201604031D0 (en) Compounds
GB201518950D0 (en) Compound
HK1251574A1 (en) Tetrahydrooxepinopyridine compound
GB201619531D0 (en) Compound
GB201619526D0 (en) Compound
GB201613035D0 (en) Compound
GB201608591D0 (en) Compound

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)